SCHEMBL7218110

SCHEMBL7218110

CCCOCCOc1ccc(C=O)cc1OCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.60
ALDH1A1 P00352 10/20 0.59
MAPT P10636 5/20 0.59
HPGD P15428 4/20 0.59
TDP1 Q9NUW8 3/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
NPSR1 Q6W5P4 2/20 0.59
TACR2 P21452 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 2/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KDM4E B2RXH2 3/20 0.51
KMT2A Q03164 3/20 0.50
POLB P06746 2/20 0.50
MEN1 O00255 2/20 0.50
ALOX12 P18054 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22572793 0.91 ALDH1A1 (0.65) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL11212209 0.91 ALDH1A1 (0.64) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL4948728 0.91 ALDH1A1 (0.64) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL13221144 0.86 ALDH1A1 (0.63) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL5882634 0.86 FDPS (0.69) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL493684 0.86 ALDH1A1 (0.73) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL30159697 0.86 ALDH1A1 (0.73) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL3464529 0.85 FDPS (0.69) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL3632198 0.85 ALDH1A1 (0.61) FDPSALDH1A1MAPTHPGDTDP1
SCHEMBL4940154 0.84 ALDH1A1 (0.60) FDPSALDH1A1MAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed